URL | https://www.pharmamanufacturing.com/industrynews/2 |
Source | Pharma Manufacturing |
Date Published | 05/12/2021 |
Mentions specific company case(s) of reshoring, kept from offshoring, or transplant | Yes |
Company/Division name | Avantor |
Type of work | Manufacturing |
Reshoring category: | Reshoring |
Year reshoring announced: | 2021 |
Domestically, the work will be done: | In-house |
State(s) reshored to: | NC |
If relevant, work nearshored to: | - |
Industry(ies): | Chemicals |
Product(s) reshored | single use technologies (pharma) |
What domestic positive factors made reshoring more attractive? | , covid-19 |